Reducing Unnecessary Implantable Cardioverter‐Defibrillator Therapy With ENHANCED Programming: Long‐Term Outcomes of the ENHANCED‐ICD Study

Documenti analoghi

• From Clinic to Cloud: Efficacy of AI‐Assisted Remote Monitoring of Patients With Implantable Cardiac Devices
  di: Cheyenne S. L. Chiu, et al.
  Pubblicazione: (2025)
• Reconsider the Indication of Implantable Cardioverter Defibrillator in Patients With Cardiac Amyloidosis
  di: Naoya Kataoka, et al.
  Pubblicazione: (2024)
• Outcomes in Patients With Mitral Annular Disjunction and an Implantable‐Cardioverter Defibrillator
  di: Fatima M. Ezzeddine, et al.
  Pubblicazione: (2025)
• In Response to: Reconsider the Indication of Implantable Cardioverter Defibrillator in Patients With Cardiac Amyloidosis
  di: Ojasav Sehrawat, et al.
  Pubblicazione: (2024)
• Safety and Clinical Outcome of Subcutaneous Implantable Cardioverter‐Defibrillators in an Asian Population: A Prospective Study
  di: Karen Ka Ying Li, et al.
  Pubblicazione: (2025)